From: Overexpression of MALT1-A20-NF-κB in adult B-cell acute lymphoblastic leukemia
No. | Clinical stage | Sex | Age | WBC (×109/L) | Blast cells (%) | Hb | Platelets (×109/L) |
---|---|---|---|---|---|---|---|
C1 | De novo | M | 31 | 3.49 | 94 | 111 | 10 |
C2 | De novo | M | 71 | 7.99 | 17.3 | 83 | 118 |
C3 | De novo | M | 28 | 41.9 | 91.9 | 104 | 15 |
C4 | De novo | M | 31 | 7.68 | 71 | 110 | 28 |
C5 | De novo | F | 16 | 62.3 | 95 | 76 | 24 |
C6 | De novo | M | 16 | 144.7 | 63 | 68 | 76 |
C7 | De novo | F | 72 | 17.44 | 82 | 93 | 20 |
C8 | De novo | F | 18 | 33.92 | 60 | 58 | 4 |
C9 | De novo | F | 17 | 2.5 | 59 | 106 | 29 |
C10 | De novo | M | 38 | 29.54 | 82 | 53 | 41 |
C11 | De novo | F | 20 | 4.5 | 86 | 57 | 8 |
C12 | De novo | M | 26 | 27.5 | 88 | 49 | 24 |
C13 | Refractory/relapse | M | 26 | 13.3 | 41 | 113 | 69 |
C14 | Refractory/relapse | F | 16 | 18.68 | 33.8 | 98 | 93 |
C15 | Refractory/relapse | F | 47 | 10.57 | 82.5 | 86 | 15 |
C16 | Refractory/relapse | M | 40 | 4.75 | 41.5 | 79 | 74 |
C17 | Refractory/relapse | F | 31 | 11.2 | 3.5 | 105 | 110 |
C18 | Refractory/relapse | F | 30 | 61.6 | 54.5 | 108 | 197 |
C19 | Refractory/relapse | M | 17 | 3.84 | 57 | 121 | 39 |
C20 | Refractory/relapse | F | 59 | 2.48 | 18 | 81 | 28 |